You buy the stock now and NHSBSA pays you for it two months later, at a price set centrally rather than at what you paid. We do the accounts for community pharmacies, and we start with the part of the business that actually decides whether it works.
The 2026/27 settlement was announced on 29 May 2026: £3.636 billion, up £340 million on the £3.296 billion agreed for 2025/26. It is a real increase and it is agreed, not proposed.
Annual accounts that separate NHS income from retail and services, the tax return behind them, and management figures that arrive while you can still act on them.
Accounts and taxThe dispensing cycle recorded as it actually behaves — you buy stock now and are reimbursed two months later — so the bank balance stops being a surprise.
BookkeepingThe FP34 schedule checked against what NHSBSA actually paid, item counts, advanced service claims and the deduction scale, so underpayments get found rather than absorbed.
NHS incomeDispensing is a working-capital business wearing a healthcare uniform. Stock is bought and paid for on the wholesaler's terms; the prescription is dispensed; the FP34 goes in; NHSBSA pays on its own schedule. The gap between those events is funded by you.
Dispensing is zero-rated, most counter sales are not, and the recovery position depends on getting that split right rather than estimating it.
VATPharmacists, technicians, dispensers, counter staff and locums — with the employment status question answered before HMRC asks it.
PayrollGoodwill, the NHS contract, whether it is a share or asset deal and whether it qualifies as a going concern for VAT — modelled before you commit.
Buying and sellingThe rules are the same size whoever you are. What changes is which of them reach you, and how much of the year they take up.
One branch, your name over the door, and a funding settlement you did not set.
More on independent pharmacy owners →Two to ten branches, where the question is which sites earn and which are carried.
More on small pharmacy groups →What the numbers have to show before the borrowing makes sense.
More on buying your first pharmacy →Self-employed rates, expenses, and whether a company is worth the admin yet.
More on locum pharmacists →A different cost base, a different margin profile, the same reimbursement rules.
More on distance-selling pharmacies →Total funding for the Community Pharmacy Contractual Framework is £3.636 billion in 2026/27, announced on 29 May 2026 — an increase of £340 million, or 10.3%, on the 2025/26 figure of £3.296 billion. Read the headline carefully, though. That £3.636 billion now includes the Pharmacy First budget, which was integrated into the CPCF for the first time; in 2025/26 that money sat outside the CPCF sum. So it is not a like-for-like comparison with the older £3.073 billion figure you may still see quoted, and any model built on treating it as one will overstate the increase to your own business.
The Single Activity Fee rises from £1.46 to £1.52 per item, an increase of 4.1%. It is backdated to take effect from May 2026, with early advanced payments from June. The SAF is the per-item fee that replaced the old bundle of professional fees, so for most contractors it is the single biggest determinant of dispensing income after the medicine margin itself. Six pence an item sounds small; multiply it by your annual item count before deciding whether it is.
Two mechanisms do this, and they are different things. The first is Category M and the margin survey: reimbursement prices are set centrally to deliver an agreed retained margin across the whole sector, not to match what any individual contractor paid. The second is the deduction scale — a clawback applied to your reimbursement, still in operation, which assumes you buy at a discount to Drug Tariff price. If you cannot buy at that discount, the deduction still applies. Concessionary prices exist to relieve the worst of it month by month, but they are granted after the fact.
Zero-rated, and the distinction matters enormously. VATA 1994 Schedule 8, Part II, Group 12, Item 1 zero-rates qualifying goods dispensed for an individual's personal use on the prescription of an appropriate practitioner, where dispensing is by a registered pharmacist. Zero-rated is a taxable supply, so it does not restrict your input tax recovery the way an exempt supply would. Counter sales of general merchandise are standard-rated. The work is in splitting the till accurately, because the split drives how much VAT you reclaim.
There is no ownership restriction equivalent to the one on law firms. A pharmacy business does not have to be owned by a pharmacist. What the law requires instead is a superintendent pharmacist where the owner is a body corporate, and a responsible pharmacist in charge of each registered premises. The registration attaches to the premises as well as the business. So the constraint on buying a pharmacy is commercial and contractual rather than a bar on who may hold the shares.
No — and this is one of the most commonly misstated points in the sector. Keeping a running balance in the CD register is strongly recommended as good practice and is what most inspectors expect to see, but it is not a legal requirement in its own right. The legal requirements are about what the register must record and how it must be kept. It is worth knowing the difference, because a policy adopted for good reasons should be adopted knowingly rather than because someone said the law demanded it.
A free review of your NHS income, your margin and the cash cycle behind them. No obligation, and you keep the analysis either way.
One short email: what has moved in the Drug Tariff, the submission dates coming up, and one number worth checking in your own figures. No spam, unsubscribe any time.